martes, 18 de diciembre de 2018

Novartis braces for a battle over the cost effectiveness of a gene therapy - STAT

Novartis braces for a battle over the cost effectiveness of a gene therapy - STAT

The Readout

Damian Garde

Novartis braces for a battle over the cost effectiveness of a gene therapy

By ED SILVERMAN @Pharmalot
DECEMBER 17, 2018
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)